Yahoo Web Search

Search results

1. • Small Business - Austin Daily Herald | Austin Daily Herald

     Austin Daily Herald· 7 days ago

     In this study, Oncocyte’s proprietary diagnostic test using droplet-digital PCR was able to identify responders and non-responders to felzartamab, showing, “a decrease in ...

2. • EMA Authorizes Hemophilia B Gene Therapy

     Medscape· 6 days ago

     The European Medicines Agency has given the go-ahead for Durveqtix to treat hemophilia B in adults and to Adzynma for patients with congenital thrombotic thrombocytopenic purpura.

3. • 

     The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...

     St. Joseph News-Press· 2 days ago

     The Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387,...

4. • 

     'Your Choice Impacts Others'

     Cape May County Herald· 7 days ago

     Editor’s Note: Cape May County ranks 15th nationwide and first in the state as a second home destination, so this summer the Herald will be periodically...

5. • 

     Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon

     Benzinga· 2 days ago

     On Friday, Pfizer Inc PFE revealed its drug for an advanced form of lung cancer showed promising...

6. • The Most Profitable Biotechnology Company in the World

     Insider Monkey via Yahoo Finance· 6 days ago

     In this article, we will be taking a look at the most profitable biotechnology company in the world. If you want to learn about more, head straight to the 15 Most Profitable Biotechnology Companies ...

7. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 3 days ago

     Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines ...

8. • Momentum Builds for Amplification-Free Molecular Diagnostics, But Significant Hurdles Remain

     GenomeWeb News· 6 days ago

     Nucleic acid amplification technologies (NAATs) are both the bedrock and biggest bottleneck of molecular diagnostics, enabling sensitive and specific infectious disease assays that also tend ...